A shadow market for unapproved weight-loss drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, according to recent findings.
Investigational Treatment Gaining Traction Via Social Media
Retatrutide, which is still in research studies, is being advertised by social media influencers for its alleged weight-reducing effects. Followers are urged to message these accounts privately for supplier links, while also receiving promotional offers.
Thriving Commerce on Messaging Platforms
Additionally, a robust trade exists on messaging services, where communities with thousands of participants share comparison photos, administration instructions and claims of rapid British shipping. Sellers promote the drug there before directing buyers to WhatsApp for purchases.
Understanding The Experimental Drug
This medication is an experimental injection created by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials suggest it could assist individuals lose up to a quarter of their total weight. Referred to as the “triple G”, the drug is being promoted digitally as the next Ozempic.
Healthcare Professionals Express Worries
However, physicians and pharmacists have cautions that the distribution of what remains an unlicensed medication in the United Kingdom is a cause for concern and could result in individuals injecting products of unknown origin.
Some professionals stated the demand for the experimental drug could be connected to the increasing cost of licensed weight loss products such as Mounjaro.
Legal Status and Enforcement
Marketing the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved medication that must not be marketed or distributed for human use under the Human Medicines Regulations 2012.
Several content creators attempt to circumvent the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but promotion and supply can still violate medicines, marketing, and customer regulations, potentially leading to fines, legal action or prison.
Platform Reaction and Content Elimination
According to TikTok, the service has removed violative content and prohibited related keywords and search suggestions. The company stated it was dedicated to keeping the service safe and investing in enhancing enforcement strategies.
Digital Marketplace Operations
Research also discovered groups with up to 9,000 participants selling the experimental drug using Telegram's built-in discovery tool, which functions like a public directory. Entering “retatrutide” immediately displays groups with thousands of members, populated with photos of slimming results, positive testimonials and step-by-step guides for mixing or injecting at home.
After minutes of joining one community, a vendor shared contact information, where most transactions take place. The seller sent an guidebook and guaranteed delivery within 48 hours. When asked whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a image of a alleged testing documentation. None inquired about weight, medical conditions or past usage.
Product Details and Pricing
Inside these communities, posts show dark colored parcels with postal service stickers, stating to include fresh supplies. One message read: “It took eight of us to load them this morning.”
Buyers can select between powder vials, mixed at home with sterile water, or pre-filled injectors typically sold at £160 for 20mg. When asked how much time a injector should be used, sellers give contradictory responses varying between a several days to “depends on your body”.
Platform Moderation and Security Measures
A representative for the messaging service said it regularly monitored dangerous content on its service including material that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Medical Professional Cautions
“People are injecting materials they can’t verify. Even if the research behind this drug is valid, these digital versions may not contain what they claim,” stated a pharmacy expert, the head of pharmacy at a pharmacy service.
A medical professional of an online medical service connected the increase in demand to current price rises for authorized weight-loss medications such as Mounjaro. “With costs increasing, individuals are using online platforms. But counterfeit treatments are extremely risky. You cannot know what’s contained or whether the conditions they were made in was sterile,” she said.
Her staff has already seen patients injured by personal administration from unconfirmed suppliers. “We understand the frustration, but buying from messaging apps or WhatsApp is gambling with your health,” said the doctor. “These substances could be impure or incorrectly dosed.”
Producer Position
A spokesperson from Eli Lilly said the substance was in third stage clinical trials and had not been reviewed or approved by any government authority globally. “Consequently at this time no one can sell [it] for human use,” they said, adding that any item “misleadingly claiming itself as a Lilly investigational product not yet authorized … may subject users to possibly significant medical dangers”.
